Global Gut Microbiota Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Gut Microbiota Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Gut Microbiota report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gut Microbiota market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Autoimmune Disorder and Gastrointestinal Disorder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gut Microbiota industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gut Microbiota key companies include Enterome, ViThera Pharmaceuticals, Ferring, Synlogic, Vedanta Biosciences, Seres Therapeutics, AOBiome and Axial Biotherapeutics, etc. Enterome, ViThera Pharmaceuticals, Ferring are top 3 players and held % share in total in 2022.
Gut Microbiota can be divided into Therapeutics, Diagnostics and Others,, etc. Therapeutics is the mainstream product in the market, accounting for % share globally in 2022.
Gut Microbiota is widely used in various fields, such as Autoimmune Disorder, Gastrointestinal Disorder, Diabetes and Obesity, etc. Autoimmune Disorder provides greatest supports to the Gut Microbiota industry development. In 2022, global % share of Gut Microbiota went into Autoimmune Disorder filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiota market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Enterome
ViThera Pharmaceuticals
Ferring
Synlogic
Vedanta Biosciences
Seres Therapeutics
AOBiome
Axial Biotherapeutics
Segment by Type
Therapeutics
Diagnostics
Others
Autoimmune Disorder
Gastrointestinal Disorder
Diabetes
Obesity
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gut Microbiota market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gut Microbiota introduction, etc. Gut Microbiota Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Gut Microbiota market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
North America, Europe and Asia Pacific are the key regions for Gut Microbiota industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gut Microbiota key companies include Enterome, ViThera Pharmaceuticals, Ferring, Synlogic, Vedanta Biosciences, Seres Therapeutics, AOBiome and Axial Biotherapeutics, etc. Enterome, ViThera Pharmaceuticals, Ferring are top 3 players and held % share in total in 2022.
Gut Microbiota can be divided into Therapeutics, Diagnostics and Others,, etc. Therapeutics is the mainstream product in the market, accounting for % share globally in 2022.
Gut Microbiota is widely used in various fields, such as Autoimmune Disorder, Gastrointestinal Disorder, Diabetes and Obesity, etc. Autoimmune Disorder provides greatest supports to the Gut Microbiota industry development. In 2022, global % share of Gut Microbiota went into Autoimmune Disorder filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gut Microbiota market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Enterome
ViThera Pharmaceuticals
Ferring
Synlogic
Vedanta Biosciences
Seres Therapeutics
AOBiome
Axial Biotherapeutics
Segment by Type
Therapeutics
Diagnostics
Others
Segment by Application
Autoimmune Disorder
Gastrointestinal Disorder
Diabetes
Obesity
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gut Microbiota market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gut Microbiota introduction, etc. Gut Microbiota Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Gut Microbiota market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.